Product Information

DUTASTERIDE-TAMSULOSIN 0.5-0.4 is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.9981 per EA under NDC 68382064016. Its NADAC has been published 428 times since Sep 12, 2018.

FDA first approved this application on May 24, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DUTASTERIDE-TAMSULOSIN 0.5-0.4

Dutasteride and tamsulosin hydrochloride
$1.9981per EA

Strength

.5; .4 mg/1; mg/1

NDC

68382064016

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207769

FDA Approved

5/24/2018

TE Code

AB

On Market Since

6/4/2018

Pharmacological Classes

5-alpha Reductase Inhibitor
5-alpha Reductase Inhibitors
Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for DUTASTERIDE-TAMSULOSIN 0.5-0.4 has been published 428 times since Sep 12, 2018, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9981 per EA
All-time high$2.8428 (Nov 11, 2020)
All-time low$1.6489 (May 22, 2024)
52-week high$2.4047
52-week low$1.8643
Median price$2.2766
Average price$2.2604
Largest weekly change+27.5% (Sep 18, 2024)
Weeks tracked428
Tracking sinceSep 12, 2018

Price History

1W

+7.2%

1M

+1.2%

3M

+1.1%

6M

-2.9%

1Y

-13.6%

3Y

-5.1%

5Y

-1.7%

All

-28.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DUTASTERIDE-TAMSULOSIN 0.5-0.4?

The current National Average Drug Acquisition Cost (NADAC) for DUTASTERIDE-TAMSULOSIN 0.5-0.4, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.9981 per EA (NDC 68382064016), effective Nov 18, 2026.

How has the price of DUTASTERIDE-TAMSULOSIN 0.5-0.4 changed over time?

Over the history we have for it, the NADAC for DUTASTERIDE-TAMSULOSIN 0.5-0.4 has declined 28.5%. It has been tracked across 428 weekly CMS publications since Sep 12, 2018.

What are the highest and lowest recorded NADAC prices for DUTASTERIDE-TAMSULOSIN 0.5-0.4?

Since Sep 12, 2018, the NADAC for DUTASTERIDE-TAMSULOSIN 0.5-0.4 has ranged from a low of $1.6489 (May 22, 2024) to a high of $2.8428 (Nov 11, 2020), with a median of $2.2766 per EA.

Are there cheaper alternatives to DUTASTERIDE-TAMSULOSIN 0.5-0.4?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DUTASTERIDE-TAMSULOSIN 0.5-0.4 in a comparable dosage form, but none are currently priced below it.

Who manufactures DUTASTERIDE-TAMSULOSIN 0.5-0.4?

DUTASTERIDE-TAMSULOSIN 0.5-0.4 (NDC 68382064016) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.